Shorter radiation for early breast cancer after breast surgery
Part of Cancer clinical trials.
This trial studies giving whole-breast radiation in a shorter, more concentrated way after breast-conserving surgery. It aims to see if this “ultra-short” schedule is effective and safe for people with early breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re female and age 18 or older.
- Your cancer is early stage and has been treated with breast-conserving surgery (not full breast removal).
- You would receive whole-breast radiation only, without radiation to nearby lymph nodes.
- Your diagnosis includes invasive (infiltrating) breast cancer and/or DCIS (a non-invasive breast cancer).
- You can legally and willingly consent to join the research.
- You do not have distance-spread cancer (no metastases).
- You do not have major reasons you cannot do radiation, like being pregnant or unable to stay in position during treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests a shorter, more targeted course of daily radiation for early-stage breast cancer. The radiation plan is adjusted each day to better fit your body, which may reduce side effects.
This trial tests a shorter course of radiation (fewer, larger doses) after breast-conserving surgery for early-stage breast cancer. The goal is to see if this approach is safe and effective for people with a low risk of cancer spread.
This study looks at giving radiation after breast surgery using a very “hypo-fractionated” schedule, meaning fewer visits with higher dose per visit. It aims to see if this approach is safe and effective for certain breast cancer and DCIS patients after complete tumor removal.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
Hear when a new Female Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.